SOURCE: Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc.

June 01, 2016 13:28 ET

Plandai Biotechnology to Host Investor Update Conference Call on Friday June 3, 2016 11a.m. ET

LONDON, UNITED KINGDOM--(Marketwired - Jun 1, 2016) -  Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare® catechin complex, today announced it will be hosting an investor update conference call for Friday, June 3, at 11a.m. Eastern Time. The call will feature Board of Directors member and vice president of sales and marketing, Mr. Callum Cottrell-Duffield. The conference call dial-in information is:

Date: June 3, 2016
Time: 11:00am ET
Call in number: (515)-604-9000
Passcode #: 754091

An archived replay of the conference call will also be available on the Company's website http://www.plandaibiotech.com/ following the broadcast. All shareholders and potential investors are welcome to participate.

Mr. Cottrell-Duffield is expected to answer questions relating to the Company's plans for filing its delinquent financial statements and returning to the OTC, recent trading volumes of the common stock, sales forecasts for the comings months, and the future direction of Plandaí.

Please send all inquiries to: info@plandaibiotechnology.com
Hannah Merrill (917)900-9827

About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. and its subsidiaries develop highly phyto-available™ extracts. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.

Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.

Contact Information